CHRISTINA RICE: Open Payments
NPI 1083357776 · BLACKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,330 in 109 payments from 12 companies in 2025. Trend: 2023 $1,415 · 2024 $1,808 · 2025 $2,330
Food & beverage: $2,230Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 32 | $608 |
| ABBVIE INC. | 18 | $604 |
| Arcutis Biotherapeutics, Inc. | 12 | $309 |
| Regeneron Healthcare Solutions, Inc. | 9 | $156 |
| Galderma Laboratories, L.P. | 18 | $138 |
| Amgen Inc. | 4 | $138 |
| Lilly USA, LLC | 5 | $98 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| UCB, Inc. | 2 | $65 |
| GENZYME CORPORATION | 2 | $48 |
Products named: TREMFYA, RINVOQ, Zoryve, DUPIXENT, SKYRIZI, NEMLUVIO, OTEZLA, TALTZ.
Industry payments across VA — which companies pay providers there.
